Using TCR-CDR3-Seq analysis (40, 41) , we measured TCR repertoires of donor CD4+ and CD8+ T cells before HCT and in GVHD target tissues (liver and gut) at 6 days after HCT. This evidence concerns the gene CD4 and graft versus host disease.